In addition, Guo et al. found that IL-10/Fc can produce effective T-cell metabolic reprogramming through upregulation of oxidative phosphorylation, which could rejuvenate depleted T cells and augment the cancer immunotherapy response [183]. Here, IL10 is linked to cancer.